Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
167.17
65.64
50.48
0.08
35.11
16.89
33.54
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
167.17
65.64
50.48
0.08
35.11
16.89
33.54
Raw Material Cost
69.84
85.57
54.22
60.99
60.49
56.87
54.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
34.14
33.62
26.35
31.43
27.29
24.61
27.04
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.21
0.00
0.00
0.00
0.00
4.04
1.21
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
-4.03
-3.36
-2.64
-3.14
-2.73
-2.86
-2.82
Total Expenditure (Excl Depreciation)
69.84
85.57
54.22
60.99
60.49
56.87
54.24
Operating Profit (PBDIT) excl Other Income
97.30000000000001
-19.9
-3.7
-60.9
-25.4
-40
-20.7
Other Income
0.61
1.66
3.29
0.74
0.30
1.23
0.36
Operating Profit (PBDIT)
99.02
-17.32
0.01
-59.55
-24.49
-38.05
-19.60
Interest
6.21
0.00
0.00
0.00
0.00
4.04
1.21
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.01
Gross Profit (PBDT)
97.33
-19.93
-3.73
-60.91
-25.38
-39.98
-20.70
Depreciation
1.07
0.96
0.45
0.62
0.59
0.70
0.74
Profit Before Tax
91.74
-18.28
-0.44
-60.17
-25.08
-42.79
-21.54
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
91.74
-18.28
-0.44
-60.17
-25.08
-42.79
-21.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
91.74
-18.28
-0.44
-60.17
-25.08
-42.79
-21.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
91.74
-18.28
-0.44
-60.17
-25.08
-42.79
-21.54
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.1
0.1
0.1
0.1
0.0
0.1
Reserves
119.18
9.27
27.77
28.19
70.45
9.14
11.02
Earnings per share (EPS)
0.99
-0.26
-0.01
-1.41
-0.71
-2.03
-1.41
Diluted Earnings per share
0.99
-0.26
-0.01
-1.41
-0.71
-2.03
-1.41
Operating Profit Margin (Excl OI)
58.22%
-30.37%
-7.39%
-73384.34%
-72.28%
-236.81%
-61.72%
Gross Profit Margin
55.52%
-26.38%
0.02%
-71749.4%
-69.75%
-249.3%
-62.0%
PAT Margin
54.88%
-27.84%
-0.87%
-72493.98%
-71.43%
-253.43%
-64.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 154.88% vs 29.90% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 601.09% vs -4,475.00% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 617.89% vs -475.76% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Sprint Bioscience AB With
Figures in Million
Consolidate Annual Results
Change(SEK)
Change(%)
Net Sales
167.17
0.00
167.17
Other Operating Income
0.00
0.00
0.00
Total Operating income
167.17
0.00
167.17
Raw Material Cost
69.84
0.00
69.84
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
34.14
0.00
34.14
Power Cost
0
0
0.00
Manufacturing Expenses
6.21
5.51
0.70
12.70%
Selling and Distribution Expenses
0.00
17.31
-17.31
-100.00%
Other Expenses
-4.03
5.13
-9.16
-178.56%
Total Expenditure (Excl Depreciation)
69.84
74.13
-4.29
-5.79%
Operating Profit (PBDIT) excl Other Income
97.33
-74.13
171.46
231.30%
Other Income
0.61
2.92
-2.31
-79.11%
Operating Profit (PBDIT)
99.02
-71.21
170.23
239.05%
Interest
6.21
5.51
0.70
12.70%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
97.33
0.00
97.33
Depreciation
1.07
0.00
1.07
Profit Before Tax
91.74
-76.72
168.46
219.58%
Tax
0.00
-0.47
0.47
100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
91.74
-76.25
167.99
220.31%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
91.74
-76.25
167.99
220.31%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
91.74
-76.25
167.99
220.31%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
119.18
99.47
19.71
19.82%
Earnings per share (EPS)
0.99
-0.67
1.66
247.76%
Diluted Earnings per share
0.99
-0.67
1.66
247.76%
Operating Profit Margin (Excl OI)
58.22%
0.00%
0.00
58.22%
Gross Profit Margin
55.52%
0.00%
0.00
55.52%
PAT Margin
54.88%
0.00%
0.00
54.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 16.72 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 154.88% vs 29.90% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 9.17 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 601.09% vs -4,475.00% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.84 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 617.89% vs -475.76% in Dec 2024
Annual - Interest
Interest 0.62 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 58.22%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






